| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- |
| filingDate |
1998-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2000-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AR-013165-A1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE |
| abstract |
The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg / ml eletriptan hemisulfate and 0.5 to 2.0% w / v caffeine. |
| priorityDate |
1997-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |